Managing Pharmaceutical Expenditure while Increasing Access

• 1 January 1999
• journal article
• Published by Springer Nature in PharmacoEconomics
• Vol. 16  (6) , 649-660
• https://doi.org/10.2165/00019053-199916060-00004

Abstract

Keywords

• HMG COA REDUCTASE INHIBITORS
• HEALTH POLICY
• COST ANALYSIS
• HMG COA REDUCTASE INHIBITOR